Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The effect of grape seed extract on estrogen levels of postmenopausal women: a pilot study.

Wahner-Roedler DL, Bauer BA, Loehrer LL, Cha SS, Hoskin TL, Olson JE.

J Diet Suppl. 2014 Jun;11(2):184-97. doi: 10.3109/19390211.2013.859220.

2.

Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.

Kijima I, Phung S, Hur G, Kwok SL, Chen S.

Cancer Res. 2006 Jun 1;66(11):5960-7.

3.

Breast cancer prevention--clinical trials strategies involving aromatase inhibitors.

Goss PE.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):487-93. Review.

PMID:
14623548
4.
5.

Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients.

Baumgart J, Nilsson K, Stavreus Evers A, Kunovac Kallak T, Kushnir MM, Bergquist J, Sundström Poromaa I.

Climacteric. 2014 Feb;17(1):48-54. doi: 10.3109/13697137.2013.800039. Epub 2013 Jun 28.

PMID:
23647561
6.

Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.

Folkerd EJ, Dixon JM, Renshaw L, A'Hern RP, Dowsett M.

J Clin Oncol. 2012 Aug 20;30(24):2977-80. doi: 10.1200/JCO.2012.42.0273. Epub 2012 Jul 16.

PMID:
22802308
7.

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.

Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.

Fertil Steril. 2003 Mar;79(3):534-42.

PMID:
12620436
8.

Postmenopausal breast cancer, androgens, and aromatase inhibitors.

Campagnoli C, Pasanisi P, Castellano I, Abbà C, Brucato T, Berrino F.

Breast Cancer Res Treat. 2013 May;139(1):1-11. doi: 10.1007/s10549-013-2505-2. Epub 2013 Apr 10. Review.

PMID:
23572296
9.
10.

Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.

Goss PE, Clark RM, Ambus U, Weizel HA, Wadden NA, Crump M, Walde D, Tye LM, De Coster R, Bruynseels J.

Clin Cancer Res. 1995 Mar;1(3):287-94.

11.

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.

Lønning PE, Haynes BP, Dowsett M.

Eur J Cancer. 2014 Apr;50(6):1055-64. doi: 10.1016/j.ejca.2014.01.007. Epub 2014 Feb 4.

12.

Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.

Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA, Dickler MN, Silverman P, Fleming GF, Kommareddy A, Jamalabadi-Majidi S, Crowder R, Siegel BA.

JAMA. 2009 Aug 19;302(7):774-80. doi: 10.1001/jama.2009.1204.

13.

Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.

Hubalek M, Oberguggenberger A, Beer B, Meraner V, Sztankay M, Oberacher H, Schubert B, Wildt L, Seeber B, Giesinger J, Kemmler G, Holzner B, Sperner-Unterweger B.

Clin Breast Cancer. 2014 Aug;14(4):291-6. doi: 10.1016/j.clbc.2013.12.008. Epub 2013 Dec 27.

PMID:
24468298
14.

Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.

Mousa NA, Crystal P, Wolfman WL, Bedaiwy MA, Casper RF.

Menopause. 2008 Sep-Oct;15(5):875-84. doi: 10.1097/gme.0b013e31816956c3.

PMID:
18480735
15.

Sex hormones and breast cancer risk and prognosis.

Folkerd E, Dowsett M.

Breast. 2013 Aug;22 Suppl 2:S38-43. doi: 10.1016/j.breast.2013.07.007. Review.

PMID:
24074790
17.

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Geisler J.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):245-53. Review.

PMID:
14623518
18.

Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review.

Behan LA, Amir E, Casper RF.

Menopause. 2015 Mar;22(3):342-50. doi: 10.1097/GME.0000000000000426. Review.

PMID:
25692874
19.

Concentration effects of grape seed extracts in anti-oral cancer cells involving differential apoptosis, oxidative stress, and DNA damage.

Yen CY, Hou MF, Yang ZW, Tang JY, Li KT, Huang HW, Huang YH, Lee SY, Fu TF, Hsieh CY, Chen BH, Chang HW.

BMC Complement Altern Med. 2015 Mar 29;15:94. doi: 10.1186/s12906-015-0621-8.

Supplemental Content

Support Center